Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Lilly continues to develop compounds for postmenopausal syndrome

April 2, 1997

Oxford Molecular/PolyMASC collaborate on development of blood growth factor

April 1, 1997

Ares-Serono and Fournier reach U.S. development and marketing agreement for HRT products

April 1, 1997

Hypoglycemic/hypolipidemic agents from Sankyo

April 1, 1997

Theratechnologies reports development strategy for second GRF analogue

March 27, 1997

Allelix prepares PTH variants for osteoporosis

March 27, 1997

Rhone-Poulenc Rorer's Granocyte approved for additional indication

March 27, 1997

Novel recombinant protein for bone diseases from Hoechst

March 26, 1997

Hypoglycemic/hypolipidemic agents from Kyorin

March 26, 1997

Sankyo prepares ACAT inhibitors

March 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...